Chief Medical Officer

Position Title: Fractional Chief Medical Officer (CMO) – Immunology / Allergy

Location: United States (Remote)

Engagement: Fractional / Part-Time

Clinical-stage biotechnology company focused on immune modulation and inflammatory disease
, with a core emphasis on allergic and immune-mediated conditions
.

The company is advancing differentiated, disease-modifying clinical programs in Allergy, supported by deep immunology expertise and a strong translational foundation.

• Provide senior medical and clinical development leadership across immune-focused and allergy programs
• Lead and evolve overall clinical development strategy, with particular emphasis on late-stage (Phase II / III) readiness
• Provide medical oversight for clinical trial design, including endpoint strategy, protocol development, and data interpretation
• Collaborate with regulatory affairs and support interactions with global regulatory agencies (e.g., FDA, EMA)
• Partner closely with Clinical Operations to support trial execution, CRO oversight, and operational feasibility
• Provide strategic guidance on portfolio prioritization and development planning in alignment with company objectives
• Support investigator engagement, key opinion leader (KOL) interactions, and external scientific collaborations
• Contribute to senior-level clinical and development decision making

• Medical degree (MD or equivalent) required
• Deep expertise in Immunology and Inflammation
  ; experience in Allergy strongly preferred
• Demonstrated leadership across multiple phases of clinical development, including late-stage programs
• Prior experience supporting Phase IIb / III trials and registrational strategy
• Track record of engagement with US and/or ex-US regulatory authorities
• Comfortable operating in a fractional / part-time executive capacity within a clinical-stage biotech environment
• Strong communication skills with the ability to partner effectively across scientific, clinical, regulatory, and operational teams